Mimedx (MDXG) Change in Taxes (2016 - 2022)
Mimedx recorded quarterly Change in Taxes of -$52000.0 in Q4 2022, up 1.89% quarter-over-quarter from -$53000.0 in Q3 2022, and down 144.07% year-over-year from $118000.0 in Q4 2021.
Mimedx's Change in Taxes history runs 7 years deep, the most recent figure standing at -$52000.0 for Q4 2022.
- In Q4 2022, Change in Taxes fell 144.07% year-over-year to -$52000.0; the TTM figure through Dec 2022 stood at -$39000.0 (up 99.58% YoY), while the FY2022 annual figure was -$39000.0, up 99.58% from the prior year.
- Change in Taxes came in at -$52000.0 for Q4 2022 at Mimedx, up from -$53000.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $10.7 million in Q1 2020 to a low of -$9.5 million in Q3 2021.
- A 5-year average of $2400.0 and a median of $11000.0 in 2018 frame the typical range for Change in Taxes.
- Across the five-year window, Change in Taxes tumbled 8350.0% in 2019 and soared 89158.33% in 2020, its largest moves.
- Mimedx's Change in Taxes stood at $10000.0 in 2018, then sank by 8350.0% to -$825000.0 in 2019, then rose by 2.06% to -$808000.0 in 2020, then surged by 114.6% to $118000.0 in 2021, then tumbled by 144.07% to -$52000.0 in 2022.
- According to Business Quant data, Change in Taxes over the past three periods registered -$52000.0, -$53000.0, and $129000.0 for Q4 2022, Q3 2022, and Q2 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -52,000.00 |
| Dec 31, 2022 | -52,000.00 |
| Sep 30, 2022 | -53,000.00 |
| Sep 30, 2022 | -53,000.00 |
| Jun 30, 2022 | 129,000.00 |
| Jun 30, 2022 | 129,000.00 |
| Mar 31, 2022 | -63,000.00 |
| Mar 31, 2022 | -63,000.00 |
| Dec 31, 2021 | 118,000.00 |
| Dec 31, 2021 | 118,000.00 |
| Sep 30, 2021 | -9.51 Mn |
| Sep 30, 2021 | -9.51 Mn |
| Jun 30, 2021 | 147,000.00 |
| Jun 30, 2021 | 147,000.00 |
| Mar 31, 2021 | -54,000.00 |
| Mar 31, 2021 | -54,000.00 |
| Dec 31, 2020 | -808,000.00 |
| Dec 31, 2020 | -808,000.00 |
| Sep 30, 2020 | 153,000.00 |
| Sep 30, 2020 | 153,000.00 |
| Jun 30, 2020 | -29,000.00 |
| Jun 30, 2020 | -29,000.00 |
| Mar 31, 2020 | 10.71 Mn |
| Mar 31, 2020 | 10.71 Mn |
| Dec 31, 2019 | -825,000.00 |
| Dec 31, 2019 | -825,000.00 |
| Sep 30, 2019 | 309,000.00 |
| Sep 30, 2019 | 309,000.00 |
| Jun 30, 2019 | 68,000.00 |
| Jun 30, 2019 | 68,000.00 |
| Mar 31, 2019 | 12,000.00 |
| Mar 31, 2019 | 12,000.00 |
| Dec 31, 2018 | 10,000.00 |
| Dec 31, 2018 | 10,000.00 |
| Sep 30, 2018 | 443,000.00 |
| Sep 30, 2018 | 443,000.00 |
| Jun 30, 2018 | -814,000.00 |
| Jun 30, 2018 | -814,000.00 |
| Mar 31, 2018 | 159,000.00 |
| Mar 31, 2018 | 159,000.00 |
| Dec 31, 2017 | -2.17 Mn |
| Dec 31, 2017 | -2.17 Mn |
| Sep 30, 2017 | 3.15 Mn |
| Sep 30, 2017 | 3.15 Mn |
| Jun 30, 2017 | -8.66 Mn |
| Jun 30, 2017 | -8.66 Mn |
| Mar 31, 2017 | 2.07 Mn |
| Mar 31, 2017 | 2.07 Mn |
| Dec 31, 2016 | -2.62 Mn |
| Dec 31, 2016 | -2.62 Mn |
| Sep 30, 2016 | 1.23 Mn |
| Sep 30, 2016 | 1.23 Mn |
| Jun 30, 2016 | 977,000.00 |
| Jun 30, 2016 | 977,000.00 |
| Mar 31, 2016 | 411,000.00 |
| Mar 31, 2016 | 411,000.00 |